Quibim, a global medical imaging analysis specialist, has joined Highlight Therapeutics, a clinical-stage company specialising in immuno-oncology, to assess the efficacy of new immunotherapy treatments in advanced melanoma skin cancer using AI in a Phase II clinical trial in Spain.
The alliance will analyse the information contained in radiological scans and correlate these findings with...
Earlier detection and advances in treatment increasingly help to treat chronic diseases and cancer in ambulatory care. While this approach has tremendously improved patients’ quality of life, it also means that they are responsible for administering their own therapy, a situation that doesn’t come free of risks.
New treatment scenarios require new tools
Home medication creates new challenges for...
AI in healthcare seems to be a hot topic of discussion around the world at the moment, but what progress has been made in terms of adoption in clinical routine?
“Improving our diagnostic and treatment processes has always been the fundamental basis of our thinking and we have welcomed AI,” Miikka Korja, chief information officer and cerebrovascular neurosurgeon at the Helsinki University Hospital...
